WST 51.32 West Pharmaceutical Services $WST Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 3:29 PM

WST 51.32 West Pharmaceutical Services $WST Hit a 52 week high of 51.37 Closing the day 09:45 at 51.32 -0.14 -0.27% With a day low of 51.12 and a total volume of 6,054.

WST Recent Posts: http://investorshangout.com/West-Pharmaceutic...WST-53126/

WST West Pharmaceutical Services Recent Headline News

Uptrend Call Working As West Pharmaceutical Services Stock Rises 20.5% (WST)
Comtex SmarTrend(R) - Wed Nov 12, 11:07AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.46% as of today's recent price of $51.16.
WST: 51.99 (+0.53)

West wins US FDA clearance for NovaGuard SA Safety System to help reduce risk of needlestick injury to healthcare workers and patients
M2 - Wed Nov 12, 7:07AM CST
Injectable drug company West Pharmaceutical Services (NYSE:WST) reported on Tuesday the receipt of the 510(k) clearance from the US Food and Drug Administration for its NovaGuard SA (Staked-needle Automatic) safety system.
WST: 51.97 (+0.51)

After Yesterday's Rally of 2.22% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 5:00PM CST
West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $50.50 to a high of $52.14. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $51.10 on volume of 661,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
WST: 51.97 (+0.51)

West Receives 510(k) Clearance for NovaGuard(TM) SA Safety System
PR Newswire - Tue Nov 11, 7:00AM CST
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from the United States Food and Drug Administration. The NovaGuard SA safety system helps reduce the risk of needlestick injuries by shielding the exposed needle of a prefilled syringe after use.
WST: 51.97 (+0.51)

Shares of WST Up 20.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 05, 9:43AM CST
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 3 months, West Pharmaceutical Services has returned 20.37% as of today's recent price of $51.12.
WST: 51.97 (+0.51)

West Pharmaceuticals: A Little Giant In The Pharma Sector
Bill Gunderson - Seeking Alpha - Mon Nov 03, 9:26AM CST
West Pharmaceutical Services ( WST ) is an example of a good stock in a good sector. I like the health care sector in the current market environment but I prefer companies that are growing at a faster pace than the Eli Lillys ( LLY ) and Mercks ( ...
WST: 51.97 (+0.51), MRK: 59.30 (-0.07), LLY: 67.64 (-0.21)

West Pharmaceutical Services Larger Than S&P 500 Component Allegheny Technologies
TheOnlineInvestor.com - Thu Oct 30, 3:43PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component West Pharmaceutical Services, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny...
WST: 51.97 (+0.51)

West Pharmaceutical Services' (WST) CEO Don Morel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:27PM CDT

WST: 51.97 (+0.51)

West Pharmaceutical Services (WST) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 7:55AM CDT

WST: 51.97 (+0.51)

West Pharmaceutical beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:16AM CDT

WST: 51.97 (+0.51)

West Pharmaceutical posts 3Q profit
Automated Insights - Thu Oct 30, 6:10AM CDT
LIONVILLE, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported net income of $31 million in its third quarter.
WST: 51.97 (+0.51)

West Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 6:02AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial objectives.
WST: 51.97 (+0.51)

West Pharmaceutical Services Shares Up 13.0% Since SmarTrend's Buy Recommendation (WST)
Comtex SmarTrend(R) - Wed Oct 29, 9:23AM CDT
SmarTrend identified an Uptrend for West Pharmaceutical Services (NYSE:WST) on August 18th, 2014 at $42.47. In approximately 2 months, West Pharmaceutical Services has returned 12.97% as of today's recent price of $47.98.
WST: 51.97 (+0.51)

West Pharmaceuticals In Q3: The Cure For What Ails You?
Kurt Avard - at Seeking Alpha - Tue Oct 28, 12:38PM CDT

WST: 51.97 (+0.51)

The Week Ahead In Earnings Reports: Pharmaceuticals
Kurt Avard - at Seeking Alpha - Sat Oct 25, 4:32PM CDT

WST: 51.97 (+0.51), PFE: 30.45 (+0.13), MRK: 59.30 (-0.07)

West Pharma Services reports October 30
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 12:22PM CDT

WST: 51.97 (+0.51)

West to Host Third Quarter 2014 Conference Call
Marketwired - Thu Oct 23, 7:01AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-280-4960 (U.S.) or 857-244-7317 (International). The passcode is 46283848.
WST: 51.97 (+0.51)

West's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark
PR Newswire - Tue Oct 21, 7:00AM CDT
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, and also the CE Mark for the European Union.
WST: 51.97 (+0.51)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Monday: GAIN, GOOD, WST
at The Street - Fri Oct 17, 9:03AM CDT
GAIN GOOD WST are going ex-dividend Monday, Monday, October 20, 2014
WST: 51.97 (+0.51), GOOD: 18.04 (-0.06), GAIN: 7.31 (unch)

West Pharmaceutical CEO to retire next year
AP - Wed Oct 15, 8:50AM CDT
NEW YORK (AP) — West Pharmaceutical Services Inc. said Wednesday that its longtime CEO Donald Morel plans to retire in May. The company, which makes syringes, medicine vials and other medical products, also narrowed its earnings outlook for the year.
WST: 51.97 (+0.51)

West Pharmaceutical Services (WST) Stock Research Links

WST Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top Tax Expert Holly Paz Joins alliant's Elite Team

Big Leagues in Tax: Holly Paz Joins alliant Tax is one of those fields that's not for the faint of heart. It's complex, ever-changing, and can make or break businesses. Enter Holly Paz, once at the helm of the IRS's Large Business & International Division, now bringing her vast experience to alliant. Paz is a bona fide heavyweight in tax administration, and her arrival at...

ASUR Scales Up: Acquires 20 Latin American Airports

A Bold Move in a Competitive Market I'll tell you, it's not every day you see a company like Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR) make a nearly billion-dollar move. This ain't some pocket change acquisition. We're talking about sealing the deal for Motiva's interests—R$5.1 billion (or nearly $992 million USD) to grab 20 airports in Brazil,...

Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

MEGA SHOW 2026: Asia's Premier Sourcing Powerhouse

MEGA SHOW 2026: Where Asian Sourcing Dreams Come True Anything worthwhile demands a veteran’s eye and a seasoned gut feeling. Swapping tales of the pavement or sifting through digital noise has me biting into MEGA SHOW Hong Kong 2026, an annual heavyweight event that stands as a prime stop on the autumn calendar for industry movers and shakers. We've circled back to the...

Student Mobility and Education: A Vital Intersection

Ritu Narayan’s Book Sparks a Vital Conversation They say never judge a book by its cover, but Ritu Narayan’s newly crowned bestseller, The Most Important Commute, begs us to look beyond the page: it's the saga of a bus ride, as mundane as rain until you peel back the layers of what it means for education today. Could something as seemingly simple as a school bus ride...

Edgewell Prepares for Key Discussion at Barclays Conference

Upcoming Fireside Chat: Edgewell's Moment of Candor Alright, folks, Edgewell Personal Care Company is about to sit in a hot seat, at the Barclays 19th Annual Global Consumer Conference. You know the deal, it’s where big shots like Rod Little, the President and CEO, and Fran Weissman, the CFO, spill the beans about where the company might be headed next. Hold on to your...

Skanska's $57M Deal to Transform Del Mar Traffic

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

OCI Energy and Arava Power Ignite SunRoper Solar Project

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

York Space Systems Faces Class Action After IPO Issues

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...